Koss-Olinger Consulting’s Vaxart VXRT Stock Holding History

Koss-Olinger Consulting’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,000	Closed	-$14K	–	293
2024 Q3	$14K	Hold	16,000	–	–	﹤0.01%	276
2024 Q2	$11K	Buy	+16,000	New	+$13.3K	﹤0.01%	266
2024 Q1	–	Sell	-16,000	Closed	-$9K	–	318
2023 Q4	$9K	Hold	16,000	–	–	﹤0.01%	314
2023 Q3	$12K	Hold	16,000	–	–	﹤0.01%	275
2023 Q2	$12K	Hold	16,000	–	–	﹤0.01%	280
2023 Q1	$12K	Buy	+16,000	New	+$14.9K	﹤0.01%	262
2021 Q4	–	Sell	-84,000	Closed	-$668K	–	260
2021 Q3	$668K	Sell	84,000 -6,000	-7%	-$49.4K	0.11%	92
2021 Q2	$674K	Hold	90,000	–	–	0.1%	112
2021 Q1	$545K	Buy	+90,000	New	+$692K	0.09%	119

Other funds holding VXRT

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Koss-Olinger Consulting's VXRT Position: Q4 2024 in Review

Koss-Olinger Consulting sold out of Vaxart (VXRT) in Q4 2024, closing a stake of 16,000 shares — an estimated $14K sold.

Koss-Olinger Consulting first reported a position in VXRT in Q1 2021 and held it in 9 quarters. The position peaked at $674K in Q2 2021. 93 funds tracked by Wall St. Rank hold VXRT as of Q4 2024.

Koss-Olinger Consulting reported no remaining Vaxart position as of Q4 2024 after selling out during the quarter.
Koss-Olinger Consulting sold 16,000 Vaxart shares in Q4 2024, an estimated $14K.
Koss-Olinger Consulting first reported a position in Vaxart in Q1 2021 and held it in 9 quarters.
Koss-Olinger Consulting's Vaxart position peaked at $674K in Q2 2021.
93 funds tracked by Wall St. Rank held Vaxart as of Q4 2024.

Based on Koss-Olinger Consulting's 13F filing for Q4 2024, filed 11 Feb 2025.